Home/Filings/4/0001209191-22-024189
4//SEC Filing

LEVIN JEREMY M 4

Accession 0001209191-22-024189

CIK 0001636651other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 5:36 PM ET

Size

5.4 KB

Accession

0001209191-22-024189

Insider Transaction Report

Form 4
Period: 2022-04-08
LEVIN JEREMY M
DirectorCEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-08+423,244423,244 total
    Exercise: $3.22Exp: 2032-04-07Common Stock (423,244 underlying)
Footnotes (1)
  • [F1]The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001256153

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:36 PM ET
Size
5.4 KB